VIR
Vir Biotechnology Inc
Price:  
7.43 
USD
Volume:  
1,477,147.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VIR WACC - Weighted Average Cost of Capital

The WACC of Vir Biotechnology Inc (VIR) is 7.4%.

The Cost of Equity of Vir Biotechnology Inc (VIR) is 9.85%.
The Cost of Debt of Vir Biotechnology Inc (VIR) is 5.00%.

Range Selected
Cost of equity 8.50% - 11.20% 9.85%
Tax rate 1.30% - 2.80% 2.05%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.7% - 8.0% 7.4%
WACC

VIR WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.02 1.13
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.50% 11.20%
Tax rate 1.30% 2.80%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.7% 8.0%
Selected WACC 7.4%